Daniel Woolson Sells 5,417 Shares of ICU Medical (NASDAQ:ICUI) Stock

ICU Medical, Inc. (NASDAQ:ICUI) VP Daniel Woolson sold 5,417 shares of ICU Medical stock in a transaction dated Thursday, August 13th. The stock was sold at an average price of $181.33, for a total transaction of $982,264.61. Following the transaction, the vice president directly owned 17,062 shares in the company, valued at $3,093,852.46. This trade represents a 24.10% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

ICU Medical Trading Up 2.1%

Shares of ICU Medical stock traded up $3.77 during mid-day trading on Thursday, hitting $183.11. The stock had a trading volume of 186,244 shares, compared to its average volume of 296,462. The firm has a 50-day moving average of $154.67 and a two-hundred day moving average of $141.46. The firm has a market cap of $4.58 billion, a P/E ratio of 155.18, a price-to-earnings-growth ratio of 2.54 and a beta of 0.74. The company has a quick ratio of 1.21, a current ratio of 2.43 and a debt-to-equity ratio of 0.56. ICU Medical, Inc. has a 12-month low of $111.42 and a 12-month high of $192.85.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings results on Thursday, August 6th. The medical instruments supplier reported $2.37 EPS for the quarter, beating the consensus estimate of $1.91 by $0.46. ICU Medical had a net margin of 1.39% and a return on equity of 7.91%. The firm had revenue of $547.88 million for the quarter, compared to analyst estimates of $533.44 million. During the same quarter in the previous year, the company earned $2.10 EPS. The business’s revenue for the quarter was up .5% compared to the same quarter last year. ICU Medical has set its FY 2026 guidance at 8.600-9.000 EPS. Sell-side analysts forecast that ICU Medical, Inc. will post 6.51 earnings per share for the current year.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the stock. Weiss Ratings upgraded shares of ICU Medical from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 23rd. KeyCorp increased their target price on shares of ICU Medical from $164.00 to $182.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 21st. Needham & Company LLC lifted their price target on shares of ICU Medical from $165.00 to $187.00 and gave the company a “buy” rating in a research report on Friday, August 7th. Piper Sandler boosted their price target on shares of ICU Medical from $163.00 to $195.00 and gave the company an “overweight” rating in a research note on Friday, August 7th. Finally, Wall Street Zen upgraded shares of ICU Medical from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 8th. Two investment analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, ICU Medical currently has a consensus rating of “Moderate Buy” and a consensus price target of $192.80.

Hedge Funds Weigh In On ICU Medical

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Maryland State Retirement & Pension System raised its position in ICU Medical by 2.0% in the fourth quarter. Maryland State Retirement & Pension System now owns 3,619 shares of the medical instruments supplier’s stock worth $516,000 after acquiring an additional 70 shares in the last quarter. California Public Employees Retirement System boosted its position in shares of ICU Medical by 0.3% during the 1st quarter. California Public Employees Retirement System now owns 30,461 shares of the medical instruments supplier’s stock worth $3,934,000 after purchasing an additional 90 shares in the last quarter. Oregon Public Employees Retirement Fund boosted its position in shares of ICU Medical by 1.8% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 5,631 shares of the medical instruments supplier’s stock worth $803,000 after purchasing an additional 100 shares in the last quarter. Smartleaf Asset Management LLC grew its stake in shares of ICU Medical by 11.6% during the 2nd quarter. Smartleaf Asset Management LLC now owns 969 shares of the medical instruments supplier’s stock worth $128,000 after purchasing an additional 101 shares during the period. Finally, Lido Advisors LLC grew its stake in shares of ICU Medical by 4.5% during the 4th quarter. Lido Advisors LLC now owns 2,479 shares of the medical instruments supplier’s stock worth $354,000 after purchasing an additional 106 shares during the period. 96.10% of the stock is currently owned by hedge funds and other institutional investors.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.